Common mistakes people make with GLP-1 supplements The GLP-1 supplement category is booming, and with that boom comes a predictable wave of misunderstandings, wasted money, and missed opportunities
Many peptides are not approved by regulators, and their safety, purity, and interactions are not well established
According to the Summary of Product Characteristics (SmPCs), GLP-1 medications commonly cause nausea (reported in approximately 20-40% of patients with semaglutide and 12-21% with dulaglutide), vomiting, and diarrhoea, particularly during initial treatment and dose escalation
Stronger bones and joint comfort
You cant look at someone, and say this is what their dose should be, Stevens says